Mesenchymal Stromal Cells
Verum for Epidermolysis Bullosa
Masonic Cancer Center and Medical Center Minneapolis, Minneapolis, MN
allo-APZ2-OTS +1 morePhase 3Waitlist AvailableResearch Sponsored by RHEACELL GmbH & Co. KGEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must not have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up12 months
Awards & highlights
Pivotal Trial
Study Summary
This trial will test if a new drug can be safely and effectively used to treat a rare skin condition called Recessive Dystrophic Epidermolysis Bullosa (RDEB).
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of subjects with complete target wound closure
Secondary outcome measures
Time to complete target wound closure from baseline
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: VerumExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Find a site
Who is running the clinical trial?
RHEACELL GmbH & Co. KGLead Sponsor
9 Previous Clinical Trials
402 Total Patients Enrolled
2 Trials studying Epidermolysis Bullosa
90 Patients Enrolled for Epidermolysis Bullosa
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Has Verum attained the necessary regulatory clearance from the FDA?
"According to our evaluation, verum has been awarded a safety rating of 3 due its successful completion of Phase 3 trials and the collected data illustrating efficacy."
Answered by AI
Are researchers still enrolling participants for this investigation?
"As per the information listed on clinicaltrials.gov, this trial is not currently enrolling participants. The study was first posted June 1st 2023 and last updated April 20th 2023. At present there are 24 other trials actively recruiting individuals for their studies."
Answered by AI